MedPath

Cardiotoxicity assessment by gated-single photon computed tomography (SPECT) in patients with previous breast cancer undergoing chemo- and/or radiotherapy

Not Applicable
Recruiting
Conditions
cardiotoxicity in breast cancer
Cancer - Breast
Registration Number
ACTRN12610000584033
Lead Sponsor
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS); Centro di Riferimento Oncologico di Basilicata (CROB)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

patients with previous breast cancer undergoing chemo- and or radiotherapy

Exclusion Criteria

know coronary artery disease, cardiac heart failure (CHF), hypertrophic myocardiopathy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CFR assessment by gated-SPECT[ad interim 6 months evaluation; final assessment at 48 months];CFR assessment by gated-SPECT[ad interim 6 months evaluation; final assessment at 48 months]
Secondary Outcome Measures
NameTimeMethod
il[nil]
© Copyright 2025. All Rights Reserved by MedPath